Local failure after complete resection of N0–1 non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Local failure after complete resection of N0–1 non-small cell lung cancer

Published:2011-02 Issue:2 Volume:71 Page:156-165
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Saynak Mert,Veeramachaneni Nirmal K.,Hubbs Jessica L.,Nam Jiho,Qaqish Bahjat F.,Bailey Janet E.,Chung Wonil,Marks Lawrence B.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference48 articles.

1. Stage I non-small cell lung carcinoma: really an early stage?;Rena;Eur J Cardiothorac Surg,2002

2. Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients;Kelsey;Cancer,2009

3. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival;Fujimoto;J Thorac Cardiovasc Surg,2006

4. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer;Arriagada;N Engl J Med,2004

5. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial;Douillard;Lancet Oncol,2006

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Missed Follow-up is associated with worse survival in stage I lung cancer: results from a large multi-site academic hospital system;Scientific Reports;2024-07-31

2. Effects of IFN-γ on the immunological microenvironment and TAM polarity in stage IA non-small cell lung cancer and its mechanisms;BMC Pulmonary Medicine;2024-01-22

3. A real-world study comparing perioperative chemotherapy and EGFR-tyrosine kinase inhibitors for treatment of resected stage III EGFR-mutant adenocarcinoma;BMC Cancer;2023-09-11

4. Molecular risk factors for locoregional recurrence in resected non‐small cell lung cancer;Cancer Medicine;2023-05-29

5. Genomic alterations dissection revealed MUC4 mutation as a potential driver in lung adenocarcinoma local recurrence;Translational Lung Cancer Research;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3